The recent disruptions in global chains have highlighted the value of securing critical medications like Ivermectin. Dependence on overseas manufacturers exposes nations to considerable vulnerabilities, including shipping delays, expense fluctuations, and even trade threats. Moving towards domestic sourcing of Ivermectin offers a multitude of upsid